AviSia Therapeutics

Amsterdam, Netherlands · Founded 2024 · Privately Held (backing)

Developer of antigen-specific immunotherapies intended to treat autoimmune diseases. AviSia Therapeutics is based in Amsterdam, Netherlands and was founded in 2024. It has raised $410,000.

Last price · $/share
—
Implied valuation
—
Total raised
$410K
Last round
—
Valuation — not yet established

No valuation for AviSia Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($410K) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AviSia Therapeutics with a free account
  • ·Watch AviSia Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

AviSia Therapeutics funding history

No rounds on record

No funding rounds for AviSia Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How AviSia Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For AviSia Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about AviSia Therapeutics

How much has AviSia Therapeutics raised?
AviSia Therapeutics has raised $410K in total funding across its recorded rounds.